Published On: Wed, Oct 19th, 2016

Mednax, Inc (NYSE:MD) Updated Analyst Coverage


A number of investment brokers have recently updated their price targets on shares of Mednax, Inc (NYSE:MD).

Most recent broker ratings

09/20/2016 – Mednax, Inc had its “buy” rating reiterated by analysts at Mizuho. They now have a USD 79 price target on the stock.

03/14/2016 – Mednax, Inc had its “overweight” rating reiterated by analysts at Piper Jaffray. They now have a USD 76 price target on the stock.

03/08/2016 – Mednax, Inc had its “buy” rating reiterated by analysts at Stifel Nicolaus. They now have a USD 76 price target on the stock.

03/07/2016 – Mednax, Inc had its “neutral” rating reiterated by analysts at Susquehanna. They now have a USD 70 price target on the stock.

12/02/2015 – Mednax, Inc had its “equal weight” rating reiterated by analysts at Stephens. They now have a USD 77 price target on the stock.

11/30/2015 – Mednax, Inc had its “buy” rating reiterated by analysts at Jefferies. They now have a USD 88 price target on the stock.

10/02/2015 – Citigroup began new coverage on Mednax, Inc giving the company a “neutral” rating.

09/16/2015 – JP Morgan began new coverage on Mednax, Inc giving the company a “overweight” rating. They now have a USD 94 price target on the stock.

07/31/2015 – Mednax, Inc had its “buy” rating reiterated by analysts at Dougherty & Co. They now have a USD 90 price target on the stock.

05/20/2015 – Mednax, Inc had its “buy” rating reiterated by analysts at Deutsche Bank. They now have a USD 79 price target on the stock.

05/13/2015 – Mednax, Inc had its “outperform” rating reiterated by analysts at Raymond James. They now have a USD 80 price target on the stock.

10/09/2014 – Robert W. Baird began new coverage on Mednax, Inc giving the company a “outperform” rating. They now have a USD 62 price target on the stock.

09/16/2014 – SunTrust began new coverage on Mednax, Inc giving the company a “neutral” rating. They now have a USD 62 price target on the stock.

12/17/2013 – KeyBanc began new coverage on Mednax, Inc giving the company a “hold” rating.

The share price of Mednax, Inc (NYSE:MD) was up +2.10% during the last day of trading, with a day high of 67.18. 242298 shares were traded during the last session.

The stock’s 50 day moving average is 65.92 and its 200 day moving average is 68.40. The stock’s market capitalization is 6.17B. Mednax, Inc has a 52-week low of 61.40 and a 52-week high of 83.20.

MEDNAX, Inc. is a provider of physician services, including newborn, anesthesia, maternal-fetal, teleradiology, pediatric cardiology and other pediatric subspecialty care. The Company’s national network consists of approximately 3,240 affiliated physicians, including approximately 1,100 physicians who provide neonatal clinical care, in over 30 states and Puerto Rico, within hospital-based neonatal intensive care units (NICUs), to babies born prematurely or with medical complications. It has over 250 affiliated physicians who provide maternal-fetal care to expectant mothers experiencing complicated pregnancies and obstetrical hospitalist services in many areas where its affiliated neonatal physicians practice. Its physician specialties and services include neonatal care, anesthesia and anesthesia subspecialty care, pain management, maternal-fetal care, pediatric cardiology care, and other pediatric subspecialty care. It also offers revenue cycle management and consulting services.